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Summary 
Human  granulocyte-macrophage  colony-stimulating  factor  (hGM-CSF)  receptor  (hGMR) 
consists of or and 13 subunits, and the precise stoichiometry of these subunits has remained to be 
determined. In this work, oligomerization of the 13 subunit was studied using a chemical cross- 
linker. In Ba/F3, a mouse interleukin-3--dependent cell line expressing both subunits ofhGMR 
(Ba/F3-ot,13), a protein with a molecular mass corresponding to that ofa homodimer of the 13 sub- 
unit (13 homodimer) was detected only when cells were treated with the cross-linker. Dimer- 
ization of the 13 subunit was confirmed by coimmunoprecipitation of a tagged 13 subunit with 
the wild type 13 subunit in COS7 cells. The 13 homodimer had already formed in the absence of 
hGM-CSF,  whereas stimulation with the ligand brought both o~ and 13 subunits into a com- 
plex, the result being tyrosine phosphorylation of the 13 homodimer. Tyrosine phosphorylation 
of the 13 subunit was impaired by deletion of the cytoplasmic domain of the c~ subunit without 
interfering with the association of both subunits, These results indicate that the 13 homodimer, 
which alone is insufficient for signaling, forms the functional hGMR with the a  subunit in re- 
sponse to hGM-CSF. 
G 
M-CSF  is  a  secreted protein  regulating proliferation 
and differentiation ofhematopoietic cells (1). The high- 
affinity and functional GM-CSF receptor (GMR) consists of 
0t and 13 subunits,  and both subunits  are single transmem- 
brane proteins belonging to  the  cytokine receptor super- 
family (1). The o~ subunit is specific to GMR, and the 13 sub- 
unit is shared by high-affinity receptors for IL-3 and IL-5. 
The high-affinity GMR is reconstituted when both sub- 
units are coexpressed in various species of cells (2, 3). Anal- 
yses  using  deletion  mutants  of the  a  and  13  subunits  re- 
vealed that  the  cytoplasmic domains  of both subunits  are 
required  for signal  transduction  but  not  for binding  with 
GM-CSF (4, 5).  Mutation analyses for GM-CSF also indi- 
cated that the ligand forms a heterotrimeric complex with 
both a  and 13 subunits  (6).  On the basis  of these findings, 
the  functional  GMR  was  thought  to  be  a  heterodimer 
composed of a  and  13  subunits.  However,  the  possibility 
that the  functional  GMR  exists as a larger complex con- 
taining multiple cx and 13 subunits rather than a heterodimer 
had to be excluded. 
Recent studies revealed that functional receptors take on 
configurations of subunits varying from receptor to recep- 
tor  (7).  Functional  forms  of many  cytokine  receptors  as 
well as GMR are composed of two distinct subunits. Some 
of these receptors, such as the IL-2R, require heterodimer- 
ization for activation of the  subunits  (8).  The  IL-6R also 
consists of two types of subunits, the IL-6R c~ subunit and 
gp130, its functional form is a heterotetramer composed of 
two molecules each of two subunits but not a heterodimer 
(9),  and homodimerization of gp130 was shown to be in- 
volved in activation of the receptor (10).  Thus, the stoichi- 
ometry of the subunits has to be determined to better un- 
derstand the mechanism of activation of GMR. 
We report here evidence that the 13 subunit  of the hu- 
man GMR (hGMR) formed a homodimer (13 homodimer), 
irrespective of human  GM-CSF  (hGM-CSF)  stimulation. 
The 13 homodimer, which was tyrosine phosphorylated af- 
ter  association  with  the  ot  subunit  in  response  to  hGM- 
CSF,  is  likely to  become a  component  of the  functional 
hGMR. The cytoplasmic domain of the oL subunit was re- 
quired for tyrosine phosphorylation of the 13 subunit. 
Materials and Methods 
Chemicals, Media, and Antibodies.  Recombinant hGM-CSF pro- 
duced  in  Escherichia coli was  provided by the  Schering-Plough 
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by silkworms (Bombyx  mort) was purified as described previously 
(11).  RPMI  1640 and DME were purchased from Nikken Bio- 
Medical  Laboratories  Co.,  Ltd.  (Kyoto, Japan).  FCS  was  pur- 
chased from Gibco Life Technologies, Inc. (Gaithersburg, MD). 
Bis(sulfosuccinimidyl)suberate  (BS  3) was from Pierce Chemical Co. 
(Rockford,  IL).  Horseradish peroxidase-linked sheep  anti-mouse 
Ig and the enhanced chemiluminescence (ECL) system were pur- 
chased  from Amersham Japan  Co.  Ltd.  (Tokyo, Japan).  Mouse 
mAb against hGMR cl subunit GMA-1 and rat mAb against hu- 
man common [3 subunit 5A5 (12)  were prepared in our labora- 
tory and were  used for immunoprecipitation. Rabbit polyclonal 
antibodies against the extracellular domain (anti-[3[e])  and the cy- 
toplasmic domain (positions of amino acid residues 453-544; anti- 
[3[c]) of the human common [3 subunit, respectively, were obtained 
from Medical & Biological Laboratory Co. Ltd. (Nagoya, Japan). 
Antiphosphotyrosine  mouse  mAb  4G10  was  purchased  from 
Upstate  Biotechnology,  Inc.  (Lake  Placid,  NY).  Murine ascites 
specific  to  the  hemagglutinin (HA)  epitope  (anti-HA) was  ob- 
tained from Berkeley Antibody Co.  (Richmond, CA). 
Cell Lines and Culture Conditions.  An mIL-3-dependent pro-B 
cell line Ba/F3 was maintained in RPMI 1640 medium containing 
10% FCS, 50 U/ml penicillin, 50 p,g/ml streptomycin, and 0.25 
ng/ml mIL-3. An hGM-CSF-dependent preerythroid cell line, 
M-TAT  (13),  was  obtained from Dr.  M.  Yamamoto  (Tsukuba 
University, Tsukuba, Japan).  The  cells  were  maintained in the 
same medium as Ba/F3, except for 1 ng/ml hGM-CSF instead of 
mIL-3.  A  monkey kidney cell line,  COS7,  was  maintained in 
DME  containing 10%  FCS,  50  U/ml penicillin, and 50  Ixg/ml 
streptomycin. 
Construction of Mutant Receptors.  The truncated mutants of the 
~x and 13 subunits, c1328 and ~4ss, were  constructed as described 
elsewhere (4). To construct the [3-HA subunit eDNA, a short DNA 
fragment  encoding the  epitope  for  the  anti-HA  antibody was 
linked  to  the  downstream  of FspI site  of the  truncated  [3455 
eDNA.  The amino acid sequence encoded by the epitope tag is 
p4SSSMYPYDVPDYASLGGSSSS. All cDNAs were joined down- 
stream of the SRot promoter in pME18S. 
Preparation of Protein Samples  fiom Hematopoietic Cells.  After fac- 
tor depletion, the cells  were washed and resuspended in PBS  at 
107 cells/ml. The cells were stimulated with or without 10 ng/ml 
hGM-CSF  for  10  min at  4~  The  cell surface  proteins  were 
cross-linked by treatment with  indicated concentrations of BS  3 
for 20 min at 4~  and the reactions were quenched by addition 
of 100  mM Tris-HC1, pH 7.5.  The cells were solubilized in lysis 
buffer containing  20 mM Tris-HC1, pH 7.5, 150 mM NaC1, 1 mM 
EDTA, 1% NP-40, 50 mM NaF, 100 p~M Na3VO4,  1 mM PMSF, 
1 I~g/ml pepstatin, and 2  ~g/ml leupeptin for  1 h  at 4~  After 
centrifugation, the  supematant was  incubated with an indicated 
antibody for  1  h  at  4~  followed  by further incubation in the 
presence of protein G-Sepharose for  1 h  at 4~  The immuno- 
precipitate from 10  v (Ba/F3) or 2  ￿  107 (M-TAT) cells was ana- 
lyzed by Western blotting. 
Transfection of COS7 Cells.  COS7  cells  were  transfected  by 
the DEAE-dextran method.  Cells were plated at 7  ￿  10  s cells/ 
10-cm plate at day 0.  On day 1, the growing cells  were washed 
with  PBS  and  incubated for  4  h  at  37~  in  DME  containing 
DNA  and 500  p~g/ml of DEAE-dextran without  FCS.  2.5  p~g 
each of two plasmid DNAs (receptor cDNAs or the control plas- 
mid)  were  used for  each transfection. At day 3,  the transfected 
cells  were  harvested  and  solubilized in  lysis  buffer  containing 
0.5% of Triton X-100 instead of NP-40. The [3 and [3-HA sub- 
units were immunoprecipitated and analyzed by Western blotting. 
Results 
Chemical  Cross-Linking  of Two Molecules  of the  ~3 Subunit. 
We  first  examined molecule(s)  associated  with the  [3 sub- 
unit  using  a  chemical  cross-linker  in  combination  with 
Western blotting.  The  chemical  cross-linker BS  3  is  a  hy- 
drophilic reagent and can react with cell surface proteins but 
not with  cytoplasmic proteins  (14).  Ba/F3-et,13  cells  (15), 
which  express  both  ix  and  [3  subunits  of hGMR,  were 
stimulated with  hGM-CSF  and then  treated  with  various 
concentrations of BS  3.  The  [3  subunit was  then immuno- 
precipitated with an anti-J3 subunit antibody (5A5) and an- 
alyzed  by  Western  blotting  using  the  anti-[3(e)  antibody 
(both  antibodies are  hereafter  referred  to  as  "anti-[3").  In 
Figure 1.  The 13 subunit forms a homodimer even in the absence ofhGM-CSF in Ba/F3 cells. (A) Titration of BS  3. After stimulation of Ba/F3-0t,13 
cells with hGM-CSF, the cells were incubated with the indicated concentrations ofBS  3 as described in Materials and Methods. Immunoprecipitates with 
5A5 were analyzed by Western blotting using the anti-j3(e) antibody. Both 5A5 and the anti-J3(e) antibody are represented as "anti-J3." The positions of 
the monomeric [3 subunit 03) and the cross-linked complex (arrow) are shown on the right. (B) Ba/F3-et,13 cells (lanes 1-4), Ba/F3-et,J34s  s cells (lanes 5- 
8), and M-TAT cells (lanes 9-12) were stimulated with (lanes 3, 4, 7, 8, 11, and 12) or without (lanes 1, 2, 5, 6, 9, and 10) hGM-CSF, and their surface 
proteins were cross-linked with (lanes 2, 4, 6, 8, I0, and 12) or without (lanes 1, 3, 5, 7, 9, and 11) 0.3 mMBS  3. The cross-linked proteins were immu- 
noprecipitated and analyzed by Western blotting under the same conditions described in A. The positions of the monomeric (m) and dimeric (d) 13 or [345  s 
subunits are shown on the right. 
1912  Homodimerization of the [3 Subunit of Human GM-CSF Receptor Figure 2.  Formation of the [3-homodimer 
in COS7 cells. (A) Schematic representation 
of the structures of  the wild-type [3 [[3(w.t.)] 
and chimeric [3-HA subunits and modes of 
recognition by the  anti-[3(c) and anti-HA 
antibodies. (B) COS7 cells were transfected 
with each of the J3(w.t.) (lanes I and 4) and 
[3-HA (lanes 2 and 5) subunit cDNAs, or 
with both  (lanes 3 and 6), by the DEAE- 
dextran method. Proteins were  immuno- 
precipitated using either the anti-HA (lanes 
1-3) or anti-[3(c) (lanes 4-6) antibody, and 
then analyzed by Western blotting using the 
(A)  anti-HA  and  (/3) anti-[3(c) antibodies. 
Positions of the wild type [3 and [3-HA  sub- 
units and an IgH chain are shown on th, 
right. 
the absence of BS  3, only a monomeric [3 subunit (13 mono- 
mer)  was detected  as  a  130-kD protein  (Fig.  1 A).  Treat- 
ment with  tunicamycin,  an  inhibitor  of glycosylation, re- 
vealed that  the  duplicated bands  of the  [3 monomer were 
due to differences in glycosylation (data not shown). Upon 
treatment  with  BS  3,  there  was  evidence  of an  additional 
260  kD  protein  recognized  by  the  anti-13  antibody.  The 
molecular mass of this protein was twice as large as that of 
the  [3 monomer.  The most efficient cross-linking was ob- 
served  at 0.3  mMBS 3, and a  higher concentration of BS  3 
slightly impaired the efficiency ofimmunoprecipitation with 
the anti-J3 antibody. The  [3 monomer was always detected 
under  these  conditions.  Thus,  only part  of the  [3  subunit 
can be cross-linked.  Whether only a fraction of the 13 sub- 
unit  exists  in  the  260-kD  complex or whether  the  cross- 
linking reaction used was inefficient was not determined. 
To  determine  if  the  260-kD  BS3-1inked  protein  was 
composed of two molecules of the [3 subunit, we did cross- 
linking  experiments  using  Ba/F3-0c,13455  cells,  which  ex- 
press the wild type ot subunit  and the mutant subunit  13455 
lacking  most  of the  cytoplasmic  domain  (4).  The  13455 
monomer was  detected  as  a  75-kD  protein,  and  an  addi- 
tional  150-kD  protein  was  seen,  depending  on  chemical 
cross-linking,  with 0.3  mM BS  3 (Fig.  1  B, lanes  7 and  8). 
These results strongly suggest that two  molecules of the  13 
or 13455 subunit were cross-linked with BS  3, under the con- 
ditions of our experiment. 
The  cross-linked  260-  or  150-kD  protein  was  found 
even in the absence of hGM-CSF (Fig.  1 B, lanes 2 and 6). 
The  addition  of hGM-CSF  did  not  affect  patterns  of the 
bands. The chemically cross-linked 260-kD protein, which 
is similar to that in Ba/F3-oc,13 cells,  was also observed in an 
hGM-CSF-dependent  preerythroid cell line,  M-TAT  (13) 
(Fig.  1  B,  lanes  10 and  12). Western  blotting  after  SDS- 
PAGE under nonreducing conditions revealed that forma- 
tion of the protein  complex was not mediated by a  disul- 
fide bond (data not shown). 
Coimmunoprecipitation of Two  Molecules of the ~  Subunits. 
We also confirmed that the [3 subunit forms a homodimer, 
determined  by  coimmunoprecipitation  analyses  using  a 
transient  expression  system in  COS7  cells.  To  distinguish 
between  two  [3  subunits  coimmunoprecipitated,  we  con- 
structed  the  [3 subunit  with  an  epitope  tag (13-HA; Fig.  2 
A). The 13-HA subunit is a chimeric [3 subunit in which all 
of the  cytoplasmic domain  is  replaced by the  HA epitope 
tag, and the deduced molecular mass is 78 kD.  COS7 cells 
were transfected with either the wild-type [3 or 13-HA sub- 
unit cDNA or both. After solubilization of the cells, immu- 
noprecipitation  followed  by Western  blotting  were  done 
using either an antibody against the cytoplasmic domain of 
the [3 subunit (anti-13[c])  or an anti-HA antibody. The wild- 
type  [3 and chimeric  13-HA subunits  were specifically rec- 
ognized by the  anti-13(c)  and  anti-HA  antibodies,  respec- 
tively  (Fig.  2, A  and  B, lanes  1,  2,  4,  and  5).  When both 
subunits were coexpressed in COS7 cells,  they coimmuno- 
precipitated by either the anti-HA or anti-13(c)  antibody, in 
the absence  of hGM-CSF  (Fig.  2  B, lanes  3  and  6).  Since 
the  13-HA subunit  lacks  the  cytoplasmic domain  of the  [3 
subunit,  interaction between two [3 subunits is likely to be 
mediated by extracellular  and/or transmembrane  domains. 
This is consistent with the result of the chemical cross-link- 
ing experiment  using Ba/F3-oc,134s 5 cells  (Fig.  1 B).  Taken 
together,  the  [3  subunit  was  shown  to  form a  non-disul- 
fide-linked  homodimer  through  the  extracellular  and/or 
transmembrane domains, regardless  ofhGM-CSF stimulation. 
The  ~  Homodimer  Can  Be  a  Component  of a  Functional 
hGMR.  To  characterize  the  [3  homodimer  as  a  compo- 
nent of a  functional hGMR,  we examined  the  association 
with  the  oc subunit  and tyrosine phosphorylation  of itself. 
Ba/F3-oc,13  cells  were  stimulated  with  hGM-CSF  and 
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Ba/F3-a.13 cells were stimulated with (lanes 3,  4,  7, and 8) or without 
(lanes I, 2, 5 and 6) hGM-CSF, and cell surface  proteins were then cross- 
linked with (lanes 2, 4, 6, and 8) or without (lanes I, 3, 5, and 7) 0.3 mM 
BS  3. Proteins were immunoprecipitated using either GMA-1 (lanes 1-4) 
or 5A5 (lanes 5-8) and then analyzed by Western blotting using (A) anti- 
13(e) and (B) antiphosphotyrosine (anti-PY) (4G10) antibodies. Positions 
of the monomeric (m) and dimeric (d) 13 subunits are shown on the right. 
treated with BS  3, and lysates were then used for immuno- 
precipitation as described for Fig.  1  B. Both the monomer 
and the BS3-cross-linked dimer of the 13 subunit were im- 
munoprecipitated by an anti--a subunit antibody in a man- 
ner  dependent  on  stimulation with  hGM-CSF  (Fig.  3  A, 
lanes 3 and 4). Accordingly, the cross-linked [3 homodimer 
formed  a  stable  complex  with  the  e~  subunit  only in  the 
presence of hGM-CSF.  Since stimulation with hGM-CSF 
preceded cross-linking with BS  3, it is likely that the 13 sub- 
unit actually existed as a  dimer in the complex with the ot 
subunit, in the absence of the cross-linker. 
Figure 4.  The [3 subunit was activated via interaction with the cytoplas- 
rnic domain of the et subunit. Ba/F3-ot,13 (lanes 1-4) and Ba/F3-~X32s,[3 
(lanes 5-8) cells were used. The cells were stimulated with (lanes 2, 4, 6, 
and 8) or without (lanes 1, 3, 5, and 7) hGM-CSF. Proteins were irmnu- 
noprecipitated using either GMA-1 (lanes 1, 2, 5, and 6) or 5A5 (lanes 3, 
4, 7, and 8) antibody and analyzed  by Western blotting using (A) the anti- 
13(e) antibody and (B) 4G10. 
As the 13 homodimer as well as the [3 monomer were ty- 
rosine phosphorylated in response to hGM-CSF  (Fig. 3  B, 
lanes 3,  4,  7, and 8), homodimerization of the [3 subunit is 
apparently not sufficient for activation of hGMR  in the ab- 
sence of hGM-CSF. Consistent with this notion, the addi- 
tion of the cross-linker did not affect growth of Ba/F3-cx,[3 
cells in the presence or the absence ofhGM-CSF  (data not 
shown).  Although it seems that the  [3 homodimer  can be 
part of the functional hGMR  and appears to be in an inac- 
tive state, without hGM-CSF, the 13 monomer may also be 
a  functional component.  Further investigations are needed 
to  show that the  [3 homodimer is indeed essential for sig- 
naling through hGMR. 
Activation  of the 13 Subunit Requires Interaction with the Cy- 
toplasmic Domain of the a  Subunit.  The preformed (or inact- 
ive) 13 homodimer was activated via an hGM-CSF-dependent 
association with the e~ subunit. We then examined the re- 
quirement of the  cytoplasmic domain of the ot subunit for 
the activation of hGMR,  using the mutant ct subunit 0/.328 
which lacks most of the cytoplasmic domain. The 0t328 sub- 
unit did associate with the  [3 subunit in response to hGM- 
CSF (Fig. 4 A, lane 6).  However, tyrosine phosphorylation 
of the  [3  subunit  was  not  induced  in  Ba/F3-e~328,[3  cells 
(Fig. 4  B, lane 6), a finding consistent with previous obser- 
vations that the cytoplasmic domain of the oL subunit is re- 
quired for signal transduction but not for reconstitution of a 
high-affinity hGMR  (4, 5). Therefore, interaction of the cy- 
toplasmic domains of the ot subunit with the [3 homodimer 
is an important step needed to activate hGMR.  It remains 
to be determined whether the  activation of hGMR  is due 
to a  conformational change of the  [3 subunit or to recruit- 
ment  of a  molecule(s) associated with the cytoplasmic do- 
main of the ol subunit. 
Discussion 
We obtained evidence that the [3 subunit of hGMR  forms 
a  homodimer  even  in  the  absence of hGM-CSF  and  that 
the  [3  homodimer  appears to  be  a  component  of a  func- 
tional hGMR. The precise role ofdimerization of the [3 sub- 
unit in triggering hGMR  signaling is unclear. Oligomeriza- 
tion  of receptors has  been  noted for various receptors for 
cytokines and growth factors (16).  Oligomeric forms of the 
receptors are required for activation of intrinsic tyrosine ki- 
nases and for transphosphorylation of growth factor recep- 
tors.  Although  members  of the  cytokine  receptor  super- 
family have no known activity for intrinsic tyrosine kinase, 
they do associate with cytoplasmic tyrosine kinases such  as 
Janus kinases OAK)  (17);  the  [3 subunit but not the cx sub- 
unit  of hGMR  was  shown  to  associate with JAK2  (18). 
Mechanisms  involved  in  activation  of cytokine  receptors 
may be similar to  those functioning for growth factor re- 
ceptors, and JAK kinases may possibly be activated through 
association  with  oligomerized  receptors,  which  in  turn 
would oligomerize the kinases (17). If so, then the [3-homo- 
dimer may be required for oligomerization (or activation) 
of  JAK2 or other related kinases. 
1914  Homodimerization of the 13 Subunit of Human GM-CSF Receptor We also found that homodimerization of the 13 subunit is 
not sufficient for activation of hGMP,., and further interac- 
tion  with  the  cytoplasmic  domain  of the  ot subunit  is re- 
quired. Although the mechanism to activate the 13 subunit is 
unclear,  a proline-rich  motif conserved in the  cytoplasmic 
domains  of the  ot  subunits  of GMR,  IL-3R,  and  IL-5R 
seems to be important for signaling through the common 13 
subunit (5, 19) (Muto, A., unpublished results). In addition, 
our recent study showed that the cytoplasmic domain of the 
ot subunit  can be  replaced by that of the  [3  subunit  when 
reconstituting  the functional hGMR. (15). The cytoplasmic 
domain of the  13 subunit  also contains  a proline-rich  motif 
termed box1. Therefore, the three ot subunits, by using the 
proline-rich  motif,  may function  similarly with  regard  to 
the mechanism of activation of the 13 subunit. 
Recently, Jenkins et al.  (20)  reported that the  [3 subunit 
of hGMR  was constitutively activated by point mutations. 
One  (V449E)  of these  mutations  was found  in  the  trans- 
membrane domain, and this resembled the activating muta- 
tion  (V664E)  found in the  neu oncogene,  which had been 
shown to activate the Neu protein by inducing constitutive 
dimerization  (21). On the basis of the similarity, they spec- 
ulated  that  the  V449E  mutant  of the  [3  subunit  might  be 
activated  by  ligand-independent  dimerization.  However, 
we found that the wild-type 13 subunit forms a homodimer, 
even in the absence of the ligand. Thus, the mutant 13 sub- 
unit is likely to be activated by mechanisms other than the 
homodimerization mediated by the mutation. 
The  precise  stoichiometry  of the  e~ and  13  subunits  re- 
mains  an  open  question  since  we  detected  no  oligomeric 
form  of the  ot  subunit.  Nevertheless,  several lines  of evi- 
dence suggest that e~ and 13 subunits exist in a molar ratio of 
one to one in a functional hGMR.. Most cytokines, includ- 
ing  hGM-CSF,  are  composed  of four ~x helices  and  have 
similar tertiary structures  (22).  Mutation  analyses of hGM- 
CSF  revealed that its first and fourth helices were binding 
sites for the 13 and a  subunits,  respectively (6).  In addition, 
a  crystallographic  study  revealed  that  one  molecule  of 
growth hormone with a tertiary structure similar to that of 
hGM-CSF  associates with two molecules of monomeric re- 
ceptors through the first and fourth helices  (23).  It is there- 
fore  tempting  to  speculate  that  two  molecules  of hGM- 
CSF  bring  two  ot  subunits  and  one  13 homodimer  into  a 
high-aflSnity hGMR  complex. 
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